Skip to content

Clinical Trials

Tigerlily Foundation’s Clinical Trials Program is a transformational initiative to accelerate the delivery of innovative treatments to our patients, with a strategic focus on populations that are facing the highest disparities. 

Why do we do this work?

  • We know that most patients of color are not offered trials until their cancers are at a more advanced stage.

  • We know that people of color are underrepresented in clinical trials, yet have the highest mortality rates across multiple disease states.

  • We know that is unacceptable.

  • We are working to transform the clinical trial landscape by building trust and transparency, to achieve equity in clinical trials in this lifetime by holding stakeholders accountable and dismantling barriers for patients of color.

FACT #1

Black people account for less than 5% of participants in clinical trials.

(FDA 2019 Drug Trial Snapshot Summary Report)
Clinical-Trials-Picture-Fact-One-cropped
Clinical Trials 2nd Picture

FACT #2

Black women under 35 get breast cancer at two times the rate of white women and die at three times the rate.

(Lisa A. Carey. et al., “Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study,” Journal of the American Medical Association) 

FACT #3

Lack of diversity and representation in clinical trials are the primary reasons why it is not known which treatments are most effective treatments for Black women with breast cancer.

(Yedjou CG, Sims JN, Miele L, et al. Health and Racial Disparity in Breast Cancer. Adv Exp Med Biol. 2019;1152:31-49. doi:10.1007/978-3-030-20301-6_3)
Clinical Trials

Our Why

The Facts About Clinical Trials

Trial Match

CLEART

Content Library

No More Barriers

Upcoming Events/Activities

JULY TBD

FOCUS GROUP – Virtual

We are hosting a focus group dedicated to Black women with breast cancer who have not participated in a trial. We aren’t here to try to change your mind-you are the expert on you, and we respect that! Our goal with this group is to create a safe space for you to openly share your experiences, concerns, and any fears that impacted your decision. We will be holding space, listening, and learning from you-the expert! 

> CLICK HERE TO REGISTER

Our Partners & Supporters

(see full list)

Amgen
Daiichi-Sankyo-512
Web
Jan 2022 Merck Logo
lilly
Seagen-Approved-2022
220110-SANOFI-LOGO-RGB

Let’s connect on social!

Load More

Facebook Posts

Who's your why? Why have you signed the #InclusionPledge? With your continued support, we can spread awareness and put an end to these barriers! bit.ly/3J1EtSU ... See MoreSee Less
View on Facebook
Join us on for our Final Conversation in the HER2+ Empower Listening Series on Thursday, August 18 2022, at 1 pm - 2 pm ET as we explore the "HER 2+ Way Forward” with ANGEL Advocates and a Clinical Nurse Educator, Sherri Hughes.Come on their journey as we discuss our emotional wellbeing and the role of spirituality while navigating HER 2+. How has spirituality played a role in your journey?Click the link below to register!💜 us02web.zoom.us/meeting/register/tZUpfumhrD8iGtxsiJtBFAaZyZClLMTcx6Vi#her2+ #breastcancer #breastcancerresearch #BreastCancerDisparities #summit #pumabiotechnology ... See MoreSee Less
View on Facebook